MG

Mousumi Gogoi

Active Director Director DIN 10135264
DIN 10135264 First appointment Apr 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Mousumi Gogoi

Data last updated:

Mousumi Gogoi is a Director at Unguent Pharmaceuticals Private Limited (since 2023). The company operates in Healthcare. Unguent Pharmaceuticals Private Limited reported revenue of ₹37.8 Lakh (FY 2024).

DIN 10135264
Primary Designation Director
Industry Healthcare
First Appointment 26 Apr 2023
Oldest Company Age 3 yrs
Largest company Unguent Pharmaceuticals Private Limited · ₹37.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Apr 20232023₹37.8 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Unguent Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mousumi Gogoi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mousumi Gogoi

Mousumi Gogoi currently holds 1 directorship: Unguent Pharmaceuticals Private Limited (Director, since 26 Apr 2023, revenue ₹37.8 Lakh (FY 2024)).

Mousumi Gogoi was first appointed on 26 Apr 2023 as Director at Unguent Pharmaceuticals Private Limited.

The current boards of Mousumi Gogoi's companies include Dipankar Baruah (Unguent Pharmaceuticals Private Limited), Junu Rani Baruah (Unguent Pharmaceuticals Private Limited), Runjun Gogoi Neog (Unguent Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available